tiprankstipranks
Centene (CNC)
NYSE:CNC
US Market
CNC
Centene
RESEARCH TOOLSreports

Centene (CNC) Stock Forecast & Price Target

2,997 Followers
See the Price Targets and Ratings of:

CNC Analyst Ratings

Hold
14Ratings
Hold
4 Buy
8 Hold
2 Sell
Based on 14 analysts giving stock ratings to
Centene
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

CNC Stock 12 Month Forecast

Average Price Target

$42.38
▲(16.73% Upside)
Based on 14 Wall Street analysts offering 12 month price targets for Centene in the last 3 months. The average price target is $42.38 with a high forecast of $54.00 and a low forecast of $32.00. The average price target represents a 16.73% change from the last price of $36.31.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"24":"$24","61":"$61","33.25":"$33.3","42.5":"$42.5","51.75":"$51.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":54,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$54.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":42.38461538461538,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$42.38</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":32,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$32.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[24,33.25,42.5,51.75,61],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2025","6":"Oct<br/>2025","9":"Jan<br/>2026","12":"Apr<br/>2026","25":"Apr<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,33.95,35.4923076923077,37.034615384615385,38.57692307692308,40.11923076923077,41.66153846153846,43.20384615384616,44.746153846153845,46.28846153846154,47.830769230769235,49.37307692307692,50.91538461538462,52.45769230769231,{"y":54,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,33.95,34.59881656804734,35.24763313609468,35.896449704142015,36.54526627218935,37.19408284023669,37.842899408284026,38.49171597633136,39.140532544378694,39.78934911242603,40.43816568047337,41.086982248520705,41.73579881656804,{"y":42.38461538461538,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,33.95,33.800000000000004,33.650000000000006,33.5,33.35,33.2,33.050000000000004,32.9,32.75,32.6,32.45,32.3,32.15,{"y":32,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":60.45,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":59.41,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":54.91,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":56.65,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.91,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 26, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":29.62,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 29, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":35.74,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":35.37,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":37.89,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":41.15,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":42.8,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":44.6,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":33.95,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$54.00Average Price Target$42.38Lowest Price Target$32.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bank of America Securities Analyst forecast on CNC
Kevin Fischbeck
Bank of America Securities
Bank of America Securities
$32→$34
Sell
-6.36%
Downside
Reiterated
04/07/26
Centene price target raised to $34 from $32 at BofACentene price target raised to $34 from $32 at BofA
Goldman Sachs Analyst forecast on CNC
Scott Fidel
Goldman Sachs
Goldman Sachs
$32
Sell
-11.87%
Downside
Reiterated
04/06/26
Analysts Offer Insights on Healthcare Companies: Neurocrine (NASDAQ: NBIX) and Centene (NYSE: CNC)
Bernstein Analyst forecast on CNC
Lance Wilkes
Bernstein
Bernstein
$48
Buy
32.19%
Upside
Assigned
04/06/26
Bernstein Issues a Buy Rating on Centene (CNC)
J.P. Morgan Analyst forecast on CNC
John Stansel
J.P. Morgan
J.P. Morgan
$41
Hold
12.92%
Upside
Reiterated
03/25/26
J.P. Morgan Remains a Hold on Centene (CNC)
Mizuho Securities Analyst forecast on CNC
Ann Hynes
Mizuho Securities
Mizuho Securities
$47→$41
Hold
12.92%
Upside
Reiterated
03/11/26
Centene price target lowered to $41 from $47 at MizuhoCentene price target lowered to $41 from $47 at Mizuho
Barclays Analyst forecast on CNC
Andrew Mok CFA
Barclays
Barclays
$54
Buy
48.72%
Upside
Reiterated
03/11/26
Analysts Offer Insights on Healthcare Companies: Roche Holding AG (Other OTC: RHHVF), Centene (NYSE: CNC) and LifeMD (NASDAQ: LFMD)
Morgan Stanley Analyst forecast on CNC
Erin Wright
Morgan Stanley
Morgan Stanley
$38→$45
Hold
23.93%
Upside
Reiterated
03/04/26
Morgan Stanley Keeps Their Hold Rating on Centene (CNC)
Truist Financial Analyst forecast on CNC
David S Macdonald
Truist Financial
Truist Financial
$47→$49
Buy
34.95%
Upside
Reiterated
02/25/26
Truist Financial Sticks to Their Buy Rating for Centene (CNC)
Wells Fargo Analyst forecast on CNC
Stephen Baxter
Wells Fargo
Wells Fargo
$43→$44
Hold
21.18%
Upside
Reiterated
02/18/26
Centene (CNC) Gets a Hold from Wells Fargo
Deutsche Bank Analyst forecast on CNC
George Hill
Deutsche Bank
Deutsche Bank
$32→$39
Hold
7.41%
Upside
Reiterated
02/10/26
Centene price target raised to $39 from $32 at Deutsche BankCentene price target raised to $39 from $32 at Deutsche Bank
TD Cowen Analyst forecast on CNC
Ryan Langston
TD Cowen
TD Cowen
$34→$38
Hold
4.65%
Upside
Reiterated
02/10/26
Balanced Outlook: Raising Long-Term EPS and Target Price While Medicaid Headwinds Justify a Hold Rating
Oppenheimer Analyst forecast on CNC
Michael Wiederhorn
Oppenheimer
Oppenheimer
$45
Buy
23.93%
Upside
Reiterated
02/09/26
Analysts Offer Insights on Healthcare Companies: Cardiol Therapeutics (NASDAQ: CRDL) and Centene (NYSE: CNC)
Guggenheim Analyst forecast on CNC
Jason Cassorla
Guggenheim
Guggenheim
―
Hold
―
Reiterated
02/09/26
Centene (CNC) Receives a Hold from Guggenheim
Cantor Fitzgerald Analyst forecast on CNC
Sarah James
Cantor Fitzgerald
Cantor Fitzgerald
$41
Hold
12.92%
Upside
Reiterated
02/08/26
Centene (CNC) Gets a Hold from Cantor Fitzgerald
Jefferies Analyst forecast on CNC
David Windley
Jefferies
Jefferies
$43
Hold
18.42%
Upside
Reiterated
01/07/26
Jefferies Remains a Hold on Centene (CNC)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bank of America Securities Analyst forecast on CNC
Kevin Fischbeck
Bank of America Securities
Bank of America Securities
$32→$34
Sell
-6.36%
Downside
Reiterated
04/07/26
Centene price target raised to $34 from $32 at BofACentene price target raised to $34 from $32 at BofA
Goldman Sachs Analyst forecast on CNC
Scott Fidel
Goldman Sachs
Goldman Sachs
$32
Sell
-11.87%
Downside
Reiterated
04/06/26
Analysts Offer Insights on Healthcare Companies: Neurocrine (NASDAQ: NBIX) and Centene (NYSE: CNC)
Bernstein Analyst forecast on CNC
Lance Wilkes
Bernstein
Bernstein
$48
Buy
32.19%
Upside
Assigned
04/06/26
Bernstein Issues a Buy Rating on Centene (CNC)
J.P. Morgan Analyst forecast on CNC
John Stansel
J.P. Morgan
J.P. Morgan
$41
Hold
12.92%
Upside
Reiterated
03/25/26
J.P. Morgan Remains a Hold on Centene (CNC)
Mizuho Securities Analyst forecast on CNC
Ann Hynes
Mizuho Securities
Mizuho Securities
$47→$41
Hold
12.92%
Upside
Reiterated
03/11/26
Centene price target lowered to $41 from $47 at MizuhoCentene price target lowered to $41 from $47 at Mizuho
Barclays Analyst forecast on CNC
Andrew Mok CFA
Barclays
Barclays
$54
Buy
48.72%
Upside
Reiterated
03/11/26
Analysts Offer Insights on Healthcare Companies: Roche Holding AG (Other OTC: RHHVF), Centene (NYSE: CNC) and LifeMD (NASDAQ: LFMD)
Morgan Stanley Analyst forecast on CNC
Erin Wright
Morgan Stanley
Morgan Stanley
$38→$45
Hold
23.93%
Upside
Reiterated
03/04/26
Morgan Stanley Keeps Their Hold Rating on Centene (CNC)
Truist Financial Analyst forecast on CNC
David S Macdonald
Truist Financial
Truist Financial
$47→$49
Buy
34.95%
Upside
Reiterated
02/25/26
Truist Financial Sticks to Their Buy Rating for Centene (CNC)
Wells Fargo Analyst forecast on CNC
Stephen Baxter
Wells Fargo
Wells Fargo
$43→$44
Hold
21.18%
Upside
Reiterated
02/18/26
Centene (CNC) Gets a Hold from Wells Fargo
Deutsche Bank Analyst forecast on CNC
George Hill
Deutsche Bank
Deutsche Bank
$32→$39
Hold
7.41%
Upside
Reiterated
02/10/26
Centene price target raised to $39 from $32 at Deutsche BankCentene price target raised to $39 from $32 at Deutsche Bank
TD Cowen Analyst forecast on CNC
Ryan Langston
TD Cowen
TD Cowen
$34→$38
Hold
4.65%
Upside
Reiterated
02/10/26
Balanced Outlook: Raising Long-Term EPS and Target Price While Medicaid Headwinds Justify a Hold Rating
Oppenheimer Analyst forecast on CNC
Michael Wiederhorn
Oppenheimer
Oppenheimer
$45
Buy
23.93%
Upside
Reiterated
02/09/26
Analysts Offer Insights on Healthcare Companies: Cardiol Therapeutics (NASDAQ: CRDL) and Centene (NYSE: CNC)
Guggenheim Analyst forecast on CNC
Jason Cassorla
Guggenheim
Guggenheim
―
Hold
―
Reiterated
02/09/26
Centene (CNC) Receives a Hold from Guggenheim
Cantor Fitzgerald Analyst forecast on CNC
Sarah James
Cantor Fitzgerald
Cantor Fitzgerald
$41
Hold
12.92%
Upside
Reiterated
02/08/26
Centene (CNC) Gets a Hold from Cantor Fitzgerald
Jefferies Analyst forecast on CNC
David Windley
Jefferies
Jefferies
$43
Hold
18.42%
Upside
Reiterated
01/07/26
Jefferies Remains a Hold on Centene (CNC)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxx
xxx
xxx
xxx
xxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Centene

3 Months
xxx
Success Rate
33/51 ratings generated profit
65%
Average Return
+3.22%
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 3 Months would result in 64.71% of your transactions generating a profit, with an average return of +3.22% per trade.
1 Year
Michael WiederhornOppenheimer
Success Rate
26/51 ratings generated profit
51%
Average Return
+4.61%
Copying Michael Wiederhorn's trades and holding each position for 1 Year would result in 50.98% of your transactions generating a profit, with an average return of +4.61% per trade.
2 Years
xxx
Success Rate
26/51 ratings generated profit
51%
Average Return
-0.45%
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 2 Years would result in 50.98% of your transactions generating a profit, with an average return of -0.45% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CNC Analyst Recommendation Trends

Rating
Dec 25
Jan 26
Feb 26
Mar 26
Apr 26
Strong Buy
0
0
0
2
2
Buy
7
8
12
12
6
Hold
14
10
13
16
11
Sell
3
0
1
2
4
Strong Sell
0
0
0
0
0
total
24
18
26
32
23
In the current month, CNC has received 8 Buy Ratings, 11 Hold Ratings, and 4 Sell Ratings. CNC average Analyst price target in the past 3 months is 42.38.
Each month's total comprises the sum of three months' worth of ratings.

CNC Financial Forecast

CNC Earnings Forecast

Next quarter’s earnings estimate for CNC is $2.15 with a range of $0.41 to $2.89. The previous quarter’s EPS was -$1.19. CNC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year CNC has Performed in-line its overall industry.
Next quarter’s earnings estimate for CNC is $2.15 with a range of $0.41 to $2.89. The previous quarter’s EPS was -$1.19. CNC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year CNC has Performed in-line its overall industry.

CNC Sales Forecast

Next quarter’s sales forecast for CNC is $47.58B with a range of $46.91B to $48.97B. The previous quarter’s sales results were $49.73B. CNC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year CNC has Performed in-line its overall industry.
Next quarter’s sales forecast for CNC is $47.58B with a range of $46.91B to $48.97B. The previous quarter’s sales results were $49.73B. CNC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year CNC has Performed in-line its overall industry.

CNC Stock Forecast FAQ

What is CNC’s average 12-month price target, according to analysts?
Based on analyst ratings, Centene’s 12-month average price target is 42.38.
    What is CNC’s upside potential, based on the analysts’ average price target?
    Centene has 16.73% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is CNC a Buy, Sell or Hold?
          Centene has a consensus rating of Hold which is based on 4 buy ratings, 8 hold ratings and 2 sell ratings.
            What is Centene’s price target?
            The average price target for Centene is 42.38. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $54.00 ,the lowest forecast is $32.00. The average price target represents 16.73% Increase from the current price of $36.31.
              What do analysts say about Centene?
              Centene’s analyst rating consensus is a Hold. This is based on the ratings of 14 Wall Streets Analysts.
                How can I buy shares of CNC?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.